Breaking News, Promotions & Moves

SystImmune Names New Chief Medical Officer

Dr. Jonathan Cheng joins the biopharmaceutical company from Bristol Myers Squibb.

Author Image

By: Charlie Sternberg

Associate Editor

SystImmune Inc., a clinical-stage biopharmaceutical company, has appointed Dr. Jonathan Cheng as Chief Medical Officer.   Cheng joins SystImmune from Bristol Myers Squibb, where he served as the Senior Vice President and Therapeutic Area Oncology Head, overseeing late-stage clinical development of the oncology portfolio. Cheng succeeds Dr. Martin Olivo, who is leaving SystImmune to pursue external opportunities.   “I am excited to welcome Dr. Cheng to our leadership team,” said J...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters